The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses (Q45791349)

16 December 2017

title

The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses (English)

1 reference

16 December 2017

1 reference

Welliver RC

1

1 reference

16 December 2017

Kaul TN

2

1 reference

16 December 2017

Putnam TI

3

1 reference

16 December 2017

Sun M

4

1 reference

16 December 2017

Riddlesberger K

5

1 reference

16 December 2017

Ogra PL

6

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 May 1980

1 reference

16 December 2017

The Journal of Pediatrics

published in

1 reference

16 December 2017

volume

96

1 reference

16 December 2017

issue

5

1 reference

16 December 2017

page(s)

808-813

1 reference

16 December 2017

Speculation on Pathogenesis in Death from Respiratory Syncytial Virus Infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980547-6

Cell-mediated immune response to respiratory syncytial virus infection: Relationship to the development of reactive airway disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980547-6

Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980547-6

Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980547-6

An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980547-6

Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980547-6

Respiratory syncytial virus infection. Rapid diagnosis in children by use of indirect immunofluorescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980547-6

The specificity of fetal IgM: antibody or anti-antibody?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980547-6

Secondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti-IgM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980547-6

Specific IgM responses after rubella vaccination; potential application following inadvertent vaccination during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980547-6

Respiratory syncytial virus in early infancy. Circulating antibody and the severity of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980547-6

Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980547-6

THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. II. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN ANTIGEN DOSE REQUIREMENT FOR SUSTAINED SYNTHESIS, ANAMNESIS, AND SENSITIVITY TO X-IRRADIATION.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2880%2980547-6

10.1016/S0022-3476(80)80547-6

7 January 2021

Identifiers

DOI

1 reference

16 December 2017

PubMed ID

7365579

1 reference

16 December 2017